Total Funding
39
75
Total FundingSeries A raised
Growth Score
-1 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
119660
Danwang Medical is a research organization focusing on regenerative medicine and organoid technology.
Junqiang Li: Founder, Chief Executive Officer & General Manager
About the Company
Danwang Medical provides clinical transformation technology services to regenerative medicine for disease diagnosis and treatments. They also provide organoid drug sensitivity testing, organoid disease models, organoid drug development, and organoid chips. Danwang Medical is committed to applying the most recent clinical transformation technology
of regenerative medicine to disease diagnosis and treatment, new drug screening, tumor marker development and identification, and other areas in order to provide clinical personalized treatment technology and accurate, efficient, and high-quality organoids Model to new drug research and development enterprises.
